KR20000034037A - Grape seed extract as tyrosinase inhibitor - Google Patents

Grape seed extract as tyrosinase inhibitor Download PDF

Info

Publication number
KR20000034037A
KR20000034037A KR1019980051189A KR19980051189A KR20000034037A KR 20000034037 A KR20000034037 A KR 20000034037A KR 1019980051189 A KR1019980051189 A KR 1019980051189A KR 19980051189 A KR19980051189 A KR 19980051189A KR 20000034037 A KR20000034037 A KR 20000034037A
Authority
KR
South Korea
Prior art keywords
grape seed
seed extract
ethanol
tyrosinase
extract
Prior art date
Application number
KR1019980051189A
Other languages
Korean (ko)
Inventor
이윤형
이승재
장재권
박시용
이현국
배은경
Original Assignee
박인배
해태제과 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박인배, 해태제과 주식회사 filed Critical 박인배
Priority to KR1019980051189A priority Critical patent/KR20000034037A/en
Priority to CN99103166A priority patent/CN1255357A/en
Priority to JP11124735A priority patent/JP2000159681A/en
Publication of KR20000034037A publication Critical patent/KR20000034037A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3472Compounds of undetermined constitution obtained from animals or plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/02Antioxidant
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

PURPOSE: A grape seed extract as tyrosinase inhibitor is provided, which shows strong anti-oxidation activity, so can be used as a cosmetic with functions of inhibition of melanin-production, prevention of skin aging, skin protection, and whitening; a medicine for freckles, flecks, spots or hyper pigmentation during pregnancy; an anti-oxidant for food. CONSTITUTION: The process for the preparation of grape seed extract as tyrosinase inhibitor comprises of: washing, drying and pulverizing grape seed; eliminating fat by hexane; extracting with shaking incubator after adding ethanol, methanol or acetone during less than 12hrs; concentrating the extracts under decompression using rotary evaporator at 50°C; and vacuum-drying to gain powdered grape seed extract.

Description

티로시나제 저해제로서의 포도씨 추출물Grape Seed Extract as a Tyrosinase Inhibitor

본 발명은 티로시나제 (tyrosinase) 저해 활성을 가지는 포도씨 추출물 및 그 용도에 관한 것이다. 보다 상세하게는, 본 발명은 물, 에탄올, 메탄올 또는 아세톤을 사용하여 열수 또는 가열 조건에서 제조한 미백 화장료, 과잉 색소증의 치료제 및 식품 갈변 억제제로 사용될 수 있는 포도씨 추출물에 관한 것이다.The present invention relates to grape seed extract having tyrosinase inhibitory activity and its use. More specifically, the present invention relates to grape seed extract which can be used as a whitening cosmetic prepared in hot water or heating conditions using water, ethanol, methanol or acetone, a therapeutic agent for hyperpigmentation and a food browning inhibitor.

멜라닌 (melanin)은 검은 색소와 단백질의 복합체 형태를 가지는 페놀류의 생물 고분자 물질로서. 사과, 감자, 바나나의 잘린 표면이 공기 중에 노출될 때 발생하는 갈변 또는 동물의 외피, 깃털, 피부, 머리, 눈 등에서 관찰된다. 그러나 멜라닌이 과잉 생산되는 경우 피부에 기미, 주근깨 등이 형성되고 피부 노화도 촉진되며, 피부암도 유발될 수 있고, 또한 식품에서는 채소, 과일, 생선 등의 품질을 저하시키는 작용도 한다.Melanin is a biopolymer of phenols that has a complex form of black pigment and protein. Browning occurs when the cut surface of apples, potatoes, and bananas is exposed to air, or it is found on the skin, feathers, skin, hair, and eyes of animals. However, if the melanin is excessively produced, blemishes, freckles, etc. are formed on the skin, skin aging is promoted, skin cancer may also be caused, and in foods, the quality of vegetables, fruits, and fish may also be reduced.

멜라닌은 주로 티로시나제 (tyrosinase)의 작용에 의하여 생합성되는 것으로 보고되어 있다. 티로시나제는 구리 (Cu)와 결합한 효소로서, 동물, 식물, 미생물 및 사람 등에 넓게 분포되어 있고, 모노하이드록시 또는 디하이드록시 페닐알라닌 (dihydroxy-phenylalanine, DOPA) 등의 페놀 화합물에서 호기적 산화를 촉진시키며, 자외선에 심하게 노출된 피부에 멜라닌 토스 (melanintorth)를 침착시켜 피부의 노화나 손상을 유발시키는 작용을 한다. 또한, 야채 또는 과실류에서도 티로시나제 등과 같은 폴리페놀 옥시다제 (polyphenol oxidase)가 식품의 갈변화 현상을 초래한다.Melanin is reported to be biosynthesized mainly by the action of tyrosinase. Tyrosinase is an enzyme that binds to copper (Cu), which is widely distributed in animals, plants, microorganisms, and humans, and promotes aerobic oxidation in phenolic compounds such as monohydroxy or dihydroxy-phenylalanine (DOPA). In addition, it acts to cause aging or damage of skin by depositing melanintorth on the skin that is severely exposed to ultraviolet rays. In addition, polyphenol oxidase such as tyrosinase also causes browning of food in vegetables or fruits.

티로시나제에 의하여 생성이 촉매되는 동물 멜라닌은 노란색-적갈색의 페오멜라닌 (pheomelanin)과 갈색-검은색의 유멜라닌 (eumelanin)으로 구분된다. 이러한 멜라닌의 합성 과정은 티로시나제의 활성 정도에 따라 L-타이로신에서 L-3,4-디하이드록시-페닐알라닌 (DOPA, L-3,4-dihydroxy-phenylalanine)으로 하이드록시화되고, 다시 DOPA에서 도파퀴논 (dopaquinone)으로 산화되며, 도파퀴논은 류코크롬 (leucochrome)으로 산화되고, 류코크롬의 산화에 의하여 도파크롬 (dopachrome)이 생성되며, 도파크롬은 다시 5,6-디하이드록시인돌 (DHI, 5,6-dihydroxyindole)로 전환되고, 이 디하이드록시인돌이 산화적으로 중합되어 단백질과 최종적으로 결합하는 것으로 구성된다. 생체 내에는 도파크롬이 DHI로 전환되는 경로이외에도 도파크롬 토토머라제 (dopachrome tautomerase)가 작용하여 5,6-디하이드록시인돌 카르복실산 (DHICA, 5,6-dihydroxyindole carboxylic acid)으로 전환되는 새로운 경로도 있음이 보고되어 있다.Animal melanin, catalyzed by tyrosinase production, is divided into yellow-red-brown pheomelanin and brown-black eumelanin. The synthesis process of melanin is hydroxylated from L-tyrosine to L-3,4-dihydroxy-phenylalanine (DOPA, L-3,4-dihydroxy-phenylalanine) depending on the degree of tyrosinase activity, which is then guided by DOPA. It is oxidized to quinone (dopaquinone), dopaquinone is oxidized to leucochrome, dopachrome is produced by the oxidation of leucochrome, dopachrome is again 5,6-dihydroxyindole (DHI, 5,6-dihydroxyindole), which consists of oxidative polymerization of the dihydroxyindole and finally binding to the protein. In addition to the conversion of dopachrome to DHI in vivo, dopachrome tautomerase acts to convert 5,6-dihydroxyindole carboxylic acid (DHICA) into 5,6-dihydroxyindole carboxylic acid. It is also reported that there is a route.

멜라닌의 생합성 대사는 피부암과의 관련하여 최근 집중적으로 연구되고 있고, 이로부터 다양한 멜라닌 생성 저해제 등이 개발되어 의약품 산업에서 피부 질환 치료제, 화장품 산업에서 기미, 주근깨 등을 예방 및 치료하는 피부 미백제 또는 식품 산업에서 갈변 방지제 등으로 적용되고 있다. 또한, 최근에는 환경문제와 관련하여 그 수요가 급격히 증가되고 있다.The biosynthesis metabolism of melanin has recently been intensively studied in connection with skin cancer, and various melanin-producing inhibitors have been developed from this, and skin whitening agents or foods that prevent and treat skin diseases in the pharmaceutical industry and spots and freckles in the cosmetics industry. It is applied as browning inhibitor in industry. Also, in recent years, the demand is rapidly increasing in relation to environmental problems.

지금까지 멜라닌 생성 저해제의 연구는 주로 티로시나제 저해제를 개발하는 방향으로 집중되어 왔고, 대표적인 티로시나제 저해제로는 티로시나제 활성부위의 구리이온에 대한 킬레이트 형성물질, 퀴논 (quinone)류를 페놀류로 환원시키는 아스코빅산 (ascorbic acid) 등의 환원제 그리고 티로시나제 자체를 변성시키는 비설파이트 (bisulfites) 제제 등을 들 수 있다.Until now, research on melanogenesis inhibitors has been mainly focused on developing tyrosinase inhibitors, and representative tyrosinase inhibitors include ascorbic acid which reduces quinones, which are chelating agents for copper ions of tyrosinase active sites, and quinones ( reducing agents such as ascorbic acid) and bisulfites preparations that denature tyrosinase itself.

이와 같이 티로시나제 저해제가 다양한 미백제 등으로 개발되어 현재 사용되고 있지만, 여러 가지 문제점도 동시에 제기되고 있다. 실제로 기미, 주근깨, 반점 및 임신기 과색소 침착 (hyperpigmentation)과 같은 과잉 색소증 치료에 국부적으로 사용되고 있는 4-하이드록시아니솔 (4-hydroxyanisole) 및 하이드로퀴논 (hydroquinone) 등은 강력한 멜라닌 생성 저해활성은 있으나 동시에 색소세포의 변성 또는 치사를 유발하고 세포 본래의 기능을 손상시키는 등의 부작용을 나타낸다. 특히 하이드로퀴논 (hydroquinone) 계열의 화합물은 멜라닌 생합성을 저해하는 미백용 크림으로 개발되어 사용되었으나, 세포 독성으로 인한 피부 자극 또는 피부병을 유발하는 것으로 알려져 현재 일부 국가에서만 사용이 허가되고 있는 실정이다. 따라서, 미리 안정성이 입증되어 있는 천연물을 이용하여 티로시나제 저해물질을 선별하려는 시도들이 이루어지고 있다.As such, tyrosinase inhibitors have been developed and used as various whitening agents, but various problems have been raised at the same time. Indeed, 4-hydroxyanisole and hydroquinone, which are used locally to treat hyperpigmentation such as blemishes, freckles, spots, and hyperpigmentation in pregnancy, have potent melanogenesis inhibitory activities. However, at the same time, it causes side effects such as causing denaturation or lethality of pigment cells and impairing the original function of the cells. In particular, the hydroquinone-based compound was developed and used as a whitening cream that inhibits melanin biosynthesis, but is known to cause skin irritation or skin disease due to cytotoxicity, and is currently licensed only in some countries. Thus, attempts have been made to select tyrosinase inhibitors using natural products that have been previously demonstrated to be stable.

이에 본 발명자들은 천연물로부터 멜라닌 생성을 억제하는 티로시나제 저해제를 개발하기 위하여 연구하던 중, 포도씨에 폴리페놀인 축합탄닌 (condensed tannin 또는 proanthocyanidin)이 많이 함유되어 있고 포도씨 분말을 물 또는 유기용매로 추출하여 얻은 포도씨 추출물이 티로시나제 활성을 저해하여 멜라닌 생성을 효과적으로 억제함을 확인함으로써 본 발명을 완성하였다.The inventors of the present invention, while researching to develop a tyrosinase inhibitor that inhibits melanin production from natural products, grape seed contains a lot of polyphenol condensed tannin (condensed tannin or proanthocyanidin) and obtained by extracting the grape seed powder with water or an organic solvent The present invention was completed by confirming that grape seed extract effectively inhibits melanin production by inhibiting tyrosinase activity.

본 발명은 티로시나제 저해제로서의 포도씨 추출물 및 그의 다양한 용도를 제공함에 그 목적이 있다.It is an object of the present invention to provide grape seed extract and its various uses as tyrosinase inhibitors.

도 1 은 본 발명의 포도씨 추출물과 기존 하이드로퀴논의 티로시나제 저해활성을 농도에 따라 비교하여 나타낸 것이고,Figure 1 shows the comparison of the tyrosinase inhibitory activity of the grape seed extract of the present invention and the existing hydroquinone according to the concentration,

◆ : 70% 에탄올 추출물 (30℃); ■ : 70% 아세톤 추출물;◆ 70% ethanol extract (30 ° C.); ■: 70% acetone extract;

△ : 하이드로퀴논; ○ : 열수 추출물;Δ: hydroquinone; ○: hot water extract;

□ : 70% 에탄올 (90℃); ● : 70% 메탄올 (90℃)□: 70% ethanol (90 ° C.); ●: 70% Methanol (90 ℃)

도 2 는 본 발명의 포도씨 추출물의 멜라닌 생합성 저해 정도를 스트렙토마이세스 비키니엔시스 (Streptomyces bikiniensis) 균주를 사용하여 조사한 것이고,2 is to investigate the degree of inhibition of melanin biosynthesis of the grape seed extract of the present invention using a Streptomyces bikiniensis strain,

도 3 는 본 발명의 포도씨 추출물의 주근깨 및 기미 치료 효과를 사용전 및 사용후 (16주 경과)로 나누어 사진으로 나타낸 것이다.Figure 3 is a photograph of the freckles and blemish treatment effect of grape seed extract of the present invention before and after use divided by 16 weeks.

상기 목적을 달성하기 위하여, 본 발명은 물 또는 유기용매를 사용하여 추출한 티로시나제 저해 활성을 가지는 포도씨 추출물 및 그 제조방법을 제공한다. 이 때 유기용매로는 에탄올, 메탄올 또는 아세톤 등을 사용하는 것이 바람직하고, 또한 유기용매의 농도는 60 ∼ 90% 범위로 하고 열수 조건 또는 가열 조건에서 포도씨 분말을 추출하는 것이 바람직하다.In order to achieve the above object, the present invention provides a grape seed extract having a tyrosinase inhibitory activity extracted using water or an organic solvent and a method for producing the same. At this time, it is preferable to use ethanol, methanol, acetone, or the like as the organic solvent, and the concentration of the organic solvent is preferably in the range of 60 to 90%, and it is preferable to extract the grape seed powder under hydrothermal or heating conditions.

또한, 본 발명은 상기 포도씨 추출물을 유효성분으로 하는 멜라닌 생성 억제, 피부 노화 방지, 피부 보호 및 미백 기능을 가지는 화장료를 제공한다.In addition, the present invention provides a cosmetic having a melanin production inhibitory, anti-aging skin, skin protection and whitening function using the grape seed extract as an active ingredient.

또한, 본 발명은 상기 포도씨 추출물을 유효성분으로 하는 멜라닌 생성 억제제용 약학적 조성물을 제공한다. 이는 기미, 주근깨, 반점 또는 임신기 과색소 침착 (hyperpigmentation)의 치료에 사용될 수 있다.The present invention also provides a pharmaceutical composition for the production of melanin inhibitors using the grape seed extract as an active ingredient. It can be used to treat spots, freckles, spots or gestational hyperpigmentation.

또한, 본 발명은 상기 포도씨 추출물을 유효 성분으로 하여 과일, 야채 및 생선 등의 식품의 갈변을 억제하는 식품 첨가물을 제공한다.In addition, the present invention provides a food additive that suppresses the browning of foods such as fruits, vegetables and fish using the grape seed extract as an active ingredient.

이하, 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명은 티로시나제 저해활성을 가지는 포도씨 추출물을 제조하기 위하여,지방을 제거한 포도씨 분말을 물과 유기용매 등을 사용하여 다양한 온도에서 추출한다. 바람직하게는, 추출 용매와 온도에 따른 건조 수율과 폴리페놀 함량을 고려할 때 열수 추출 조건에서 60 ~ 90% 아세톤을 사용하거나 가열 조건에서 60 ~ 90% 에탄올 또는 60 ~ 90% 메탄올을 사용하여 포도씨 추출물을 제조하고, 더욱 바람직하게는 열수 추출 조건에서 70 ~ 80% 아세톤을 사용하거나 가열 조건에서 70 ~ 80% 에탄올 또는 70 ~ 80% 메탄올을 사용하여 포도씨 추출물을 제조한다.In the present invention, in order to prepare a grape seed extract having tyrosinase inhibitory activity, the grape seed powder from which fat is removed is extracted at various temperatures using water and an organic solvent. Preferably, grape seed extract using 60-90% acetone under hydrothermal extraction conditions or 60-90% ethanol or 60-90% methanol under heating conditions, taking into account extraction solvents and drying yield and polyphenol content depending on temperature To prepare a grape seed extract more preferably using 70 to 80% acetone in hot water extraction conditions or 70 to 80% ethanol or 70 to 80% methanol under heating conditions.

상기 포도씨 추출물의 티로시나제 저해 활성을 버섯 티로시나제 등을 L-디하이드록시페닐알라닌 (L-DOPA) 등과 반응시켜 측정한 흡광도로부터 조사한 결과, 상기 포도씨 추출물은 기존의 코지산 (kojic acid), 하이드로퀴논 (hydroquinone), 아부틴 (arbutin), 4-하이드록시아니솔 (4-hydroxyanisole), 아스코빅산 (ascorbic acid), 레티놀 (retinol), 하이드로코티손 (hydrocortison)보다 티로시나제 저해 활성이 우수한 것으로 나타났다 (도 1 참조). 특히 폴리페놀 함량이 높은 70 ∼ 80% 아세톤을 사용하여 얻은 포도씨 추출물과 가열 조건에서 70∼80% 에탄올 또는 메탄올을 사용하여 얻은 포도씨 추출물이 바람직한 상기 저해 활성을 나타낸다.The tyrosinase inhibitory activity of the grape seed extract was investigated from absorbance measured by reacting mushroom tyrosinase with L-dihydroxyphenylalanine (L-DOPA) and the like. ), Arbutin, 4-hydroxyanisole, ascorbic acid, ascorbic acid, retinol, hydrocortison showed superior tyrosinase inhibitory activity (see FIG. 1). . In particular, grape seed extract obtained by using 70-80% acetone having a high polyphenol content and grape seed extract obtained by using 70-80% ethanol or methanol under heating conditions exhibit the preferable inhibitory activity.

또한, 상기 포도씨 추출물의 멜라닌 생합성 저해 활성도 멜라닌을 생합성하는 미생물인 스트렙토마이세스 비키니엔시스 (Streptomyces bikiniensis) 균주 등을 이용하여 조사한다 (도 2 참조). 이 때 멜라닌 생성 저해환 (Inhibition zone, mm)의 크기를 측정한 결과, 상기 포도씨 추출물은 코지산, 하이드로퀴논, 아부틴, 4-하이드로아니솔보다 비교적 크고 깨끗한 저해환을 생성시켰다.In addition, the melanin biosynthesis inhibitory activity of the grape seed extract is investigated using Streptomyces bikiniensis strain, a microorganism that biosynthesizes melanin (see FIG. 2). As a result of measuring the size of the melanin inhibition ring (Inhibition zone, mm), the grape seed extract produced a relatively larger and cleaner inhibitory ring than kojic acid, hydroquinone, abutin, 4-hydroanisole.

따라서, 상기 포도씨 추출물은 티로시나제 활성을 저해하는 멜라닌 생성 억제제로서 기미, 주근깨, 반점 또는 임신기 과색소 침착 (hyperpigmentation) 등의 예방 및 치료에 사용될 수 있다. 또한, 상기 포도씨 추출물은 멜라닌 생성 억제, 피부 노화 방지, 피부 보호 또는 미백 기능을 가지는 화장료로도 사용되어 유연화장수, 영양화장수, 영양크림, 맛사지크림, 엣센스, 팩 등에 첨가될 수 있다 (도 3 참조). 또한, 상기 포도씨 추출물은 과일, 야채 및 생선 등의 식품의 갈변을 억제하여 신도도를 높이는 식품 첨가제로 사용될 수 있다.Therefore, the grape seed extract may be used for the prevention and treatment of melanoma, freckles, spots or hyperpigmentation as a melanin inhibitor that inhibits tyrosinase activity. In addition, the grape seed extract may also be used as a cosmetic having a melanin production inhibitory, anti-aging skin, skin protection or whitening function can be added to the softening longevity, nourishing cosmetics, nutrition cream, massage cream, essence, pack, etc. ). In addition, the grape seed extract may be used as a food additive to increase the elongation by inhibiting the browning of foods such as fruits, vegetables and fish.

상기 포도씨 추출물은 이미 독성이 없음이 확인된 식용 과일의 추출물이고, 상기 과정을 통하여 제조된 추출물이 치료용 약제로 이용되기 위해서 약제학적 분야에서 공지의 방법에 의하여 제조될 수 있으며, 그 자체 또는 약학적으로 허용되는 담체 (carrier), 부형제 (forming agent), 희석제 (diluent) 등과 혼합하여 연고제, 분말, 과립, 정제, 캡슐제 또는 주사제 등의 제형으로 제조되어 사용될 수 있다. 또한, 이들은 비경구 또는 경구로 투여되거나 피부에 도포하여 사용될 수 있다.The grape seed extract is an extract of an edible fruit that has already been confirmed to be non-toxic, and the extract prepared through the above process may be prepared by a known method in the pharmaceutical field to be used as a therapeutic agent, itself or in pharmaceuticals. It can be mixed and used in the form of ointments, powders, granules, tablets, capsules or injections by mixing with an acceptable carrier, excipient (forming agent), diluent and the like. They can also be used parenterally or orally or by application to the skin.

본 발명에 따른 유효 성분의 투여량은 체내에서 활성성분의 흡수도, 불활성화율, 배설속도, 환자의 연령, 성별 및 상태, 치료할 질병의 중증정도 등에 따라 적절히 선택되나, 일반적으로 성인에게 1일에 5 - 300 mg 정도를 사용하나 25 - 200 mg 정도를 사용하는 것이 바람직하다. 이렇게 제형화된 제제는 필요에 따라 약제의 투여를 감시하거나 관찰하는 전문가의 판단과 개인의 요구에 따라 전문화된 투약법을 사용하거나, 일정시간 간격으로 수회 투여하거나 피부에 도포할 수 있다.The dosage of the active ingredient according to the present invention is appropriately selected depending on the absorbency, inactivation rate, rate of excretion, the age, sex and condition of the patient, the severity of the disease to be treated, etc. 5 to 300 mg should be used, but 25 to 200 mg should be used. Such formulated formulations may be applied to the skin several times at regular time intervals, or by using specialized dosing regimens at the discretion of the expert who monitors or observes the administration of the agent as needed and as desired by the individual.

이하 실시예, 제조예 및 실험예에 의하여 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail by Examples, Preparation Examples and Experimental Examples.

단, 하기 실시예, 제조예 및 실험예들은 본 발명을 예시하는 것으로, 본 발명의 내용이 이들 내용에 의하여 한정되는 것은 아니다.However, the following Examples, Preparation Examples and Experimental Examples illustrate the present invention, but the content of the present invention is not limited by these contents.

<실시예 1> 포도씨 추출물의 제조<Example 1> Preparation of grape seed extract

포도씨를 수세하여 건조시키고 분쇄기로 분쇄하여 헥산으로 지방을 제거한 다음 건조시켜 얻은 포도씨 분말 100g 에 각각 추출용매로 물과 온도를 달리한 에탄올, 메탄올 또는 아세톤을 0.5 ~ 3L 첨가하여 12시간 이하로 각 추출 온도에 따라 진탕 배양기 (shaking incubator, 30℃) 또는 온도 조절 수조가 부착된 환류추출기 (60 ∼ 95℃)로 추출하였다. 다음 회전증발기 (rotary evaporator)를 사용하여 50℃에서 상기 추출물을 감압 농축시키고 다시 진공 건조시켜 분말 상태의 포도씨 추출물 (grape seed extract, G.S.E.)을 얻었다. 또한 상기 추출 용매와 추출 온도에 따라 추출전 포도씨의 중량과 추출후 건조된 포도씨 분말의 중량을 각각 측정하고 그 대비에 의하여 건조 수율을 계산하였으며, 상기 포도씨의 폴리페놀 함량은 폴린-데니스 (Follin-Dennis)법에 의하여 구하였다. 상기 추출 용매와 추출 온도에 따른 건조 수율과 폴리페놀 함량을 전체적으로 고려하였을 때, 열수추출 조건에서 70 ~ 80% 아세톤을 사용한 추출물과 가열 조건에서 70 ~ 80% 에탄올 또는 메탄올을 사용한 추출물이 가장 효과적임을 확인하였다.Wash the grape seed with water, dry it, crush it with a pulverizer to remove fat with hexane, and extract 100 g of ethanol, methanol or acetone with different solvent and water into 100 g of the grape seed powder. Depending on the temperature was extracted with a shake incubator (30 ℃) or a reflux extractor (60 ~ 95 ℃) attached to a temperature control tank. Next, the extract was concentrated under reduced pressure at 50 ° C. using a rotary evaporator and dried under vacuum to obtain a grape seed extract (G.S.E.) in powder form. In addition, the weight of the grape seed before extraction and the weight of the dried grape seed powder after extraction according to the extraction solvent and the extraction temperature were measured, respectively, and the drying yield was calculated according to the comparison, and the polyphenol content of the grape seed was determined by Folin-Denis. Obtained by the law. Considering the dry yield and polyphenol content according to the extraction solvent and the extraction temperature as a whole, the extract using 70-80% acetone in hot water extraction conditions and the extract using 70-80% ethanol or methanol under heating conditions are most effective. Confirmed.

추출 용매 및 추출 온도에 따른 포도씨 추출물 (G.S.E)의 건조 수율과 폴리페놀 함량Drying Yield and Polyphenol Content of Grape Seed Extract (G.S.E) According to Extraction Solvent and Extraction Temperature 추출 용매Extraction solvent 추출 온도 (℃)Extraction temperature (℃) 건조 수율 (%)Dry yield (%) 포도씨 추출물의 폴리페놀 함량 (%)Polyphenol Content of Grape Seed Extract (%) water 80 ∼ 9580 to 95 7.77.7 14.514.5 10% 에탄올10% ethanol 3030 2.12.1 5.15.1 40% 에탄올40% ethanol 3030 2.92.9 10.110.1 70, 80% 에탄올70, 80% Ethanol 3030 2.82.8 19.219.2 10% 에탄올10% ethanol 60 ∼ 8060 to 80 3.53.5 15.015.0 40% 에탄올40% ethanol 60 ∼ 8060 to 80 7.47.4 27.427.4 70, 80% 에탄올70, 80% Ethanol 60 ∼ 8060 to 80 7.77.7 38.238.2 99% 에탄올99% ethanol 60 ∼ 7560 to 75 1.51.5 50.050.0 10% 아세톤10% acetone 3030 2.32.3 4.04.0 40% 아세톤40% acetone 3030 4.14.1 19.019.0 70, 80% 아세톤70, 80% Acetone 3030 3.73.7 40.340.3 10% 메탄올10% methanol 60 ∼ 8060 to 80 3.03.0 14.114.1 40% 메탄올40% methanol 60 ∼ 8060 to 80 7.17.1 25.225.2 70, 80% 메탄올70, 80% methanol 60 ∼ 8060 to 80 7.57.5 35.435.4

<실시예 2> 포도씨 추출물의 티로시나제 저해 활성 조사<Example 2> Tyrosinase Inhibition Activity of Grape Seed Extract

상기 실시예 1에서 제조한 분말 상태의 포도씨 추출물의 티로시나제 저해 활성을 조사하기 위하여, 버섯 티로시나제 (mushroom tyrosinase, Sigma, E.C. 1.14.18.1)를 사용하여 저해 정도를 측정하였다. 이 때 티로시나제는 1/15 M 인산완충용액 (phosphate buffer, pH 6.8)에 1560 units/mL 농도로 녹여 냉동고에 동결보관하고, 사용시에 빙상에서 녹여 효소원으로 이용하였다. 또한 기질로는 L-3,4-디하이드록시페닐알라닌 (L-3,4-dihydroxyphenylalanine, L-DOPA)을 차광병에서 1/15M 인산 완충용액에 녹여 사용하였고, 이 용액은 사용직전에 조제하였다.In order to investigate the tyrosinase inhibitory activity of the powdered grape seed extract prepared in Example 1, the degree of inhibition was measured using mushroom tyrosinase (mushroom tyrosinase, Sigma, E.C. 1.14.18.1). At this time, tyrosinase was dissolved in 1/15 M phosphate buffer (phosphate buffer, pH 6.8) at a concentration of 1560 units / mL and stored in a freezer. As a substrate, L-3,4-dihydroxyphenylalanine (L-3,4-dihydroxyphenylalanine, L-DOPA) was dissolved in 1 / 15M phosphate buffer in a shading bottle, and the solution was prepared immediately before use. .

티로시나제 저해 활성은 티로시나제 (78 units/mL) 0.0625mL, 1/15M 인산 완충용액 1.4615mL를 함께 넣어 25℃에서 5분간 미리 반응 (preincubation)시키고 이에 상기 L-DOPA를 0.476mL 넣어 475nm에서 10분간 흡광도를 측정하였다. 즉, 티로시나제 효소와 포도씨의 용매 추출물 또는 분획물을 모두 넣은 시료군 (C), 시료 대신 동량의 1/15M 인산 완충용액을 넣은 대조군 (A), 효소 대신 1/15M 인산 완충용액을 넣은 효소 대조군 (D) 그리고 효소 및 시료 대신 1/15M 인산 완충용액을 넣은 공시험군 (B)으로 나누어 실험을 수행하였다. 각 군은 모두 3개씩 (triplicate) 반복하여 실험하였고, 아래의 수식으로부터 효소 저해율 (%)을 산출하였다. 이 때 대조군으로는 코지산 (kojic acid), 하이드로퀴논 (hydroquinone), 아부틴 (arbutin), 4-하이드록시아니솔 (4-hydroxyanisole), 아스코빅산 (ascorbic acid), 레티놀 (retinol), 하이드로코티손 (hydrocortison)을 사용하였다.Tyrosinase inhibitory activity was pre-cubated at 25 ° C. for 5 minutes by adding 0.0625 mL of tyrosinase (78 units / mL) and 1.4615 mL of 1 / 15M phosphate buffer, followed by absorbing 0.476 mL of L-DOPA for 10 minutes at 475 nm. Was measured. That is, a sample group containing both a tyrosinase enzyme and a solvent extract or fraction of grape seed (C), a control group having an equivalent amount of 1 / 15M phosphate buffer instead of the sample (A), an enzyme control having a 1 / 15M phosphate buffer instead of the enzyme ( D) And the experiment was performed by dividing the test group (B) with a 1 / 15M phosphate buffer instead of enzymes and samples. Each group was repeated three times (triplicate), and the enzyme inhibition rate (%) was calculated from the following formula. In this case, kojic acid, hydroquinone, arbutin, 4-hydroxyanisole, ascorbic acid, retinol, hydrocortisone (hydrocortison) was used.

그 결과, 폴리페놀 함량이 높았던 70∼80% 아세톤을 사용한 포도씨 추출물과 가열 조건에서 70∼80% 에탄올 및 메탄올을 사용한 포도씨 추출물이 상기 대조군보다 높은 저해 활성을 나타내었다 (도 1 참조).As a result, the grape seed extract using 70-80% acetone having a high polyphenol content and the grape seed extract using 70-80% ethanol and methanol under heating conditions showed higher inhibitory activity than the control group (see FIG. 1).

A : 시료가 없는 대조군의 475nm 에서 흡광도;A: absorbance at 475 nm of control without sample;

B : 시료와 효소가 없는 대조군의 475nm 에서 흡광도;B: absorbance at 475 nm of sample and control without enzyme;

C : 시료와 효소를 넣은 실험군의 475nm 에서 흡광도;C: absorbance at 475 nm of the experimental group containing the sample and the enzyme;

D : 효소가 없는 대조군의 475nm 에서 흡광도;D: absorbance at 475 nm of the control without enzyme;

포도씨 추출물(G.S.E.)의 티로시나제 활성에 대한 저해도 (%)Inhibition of Tyrosinase Activity of Grape Seed Extract (G.S.E.) (%) 추출 용매Extraction solvent 추출 온도 (℃)Extraction temperature (℃) 첨가 농도 (μg/mL)Concentration (μg / mL) 저해도 (%)Inhibition (%) water 80 ∼ 9580 to 95 5050 30.030.0 10% 에탄올10% ethanol 3030 5050 7.07.0 40% 에탄올40% ethanol 3030 5050 28.328.3 70, 80% 에탄올70, 80% Ethanol 3030 5050 29.429.4 10% 에탄올10% ethanol 60 ∼ 8060 to 80 5050 15.115.1 40% 에탄올40% ethanol 60 ∼ 8060 to 80 5050 30.830.8 70, 80% 에탄올70, 80% Ethanol 60 ∼ 8060 to 80 5050 58.158.1 99% 에탄올99% ethanol 60 ∼ 8060 to 80 5050 61.161.1 10% 아세톤10% acetone 3030 5050 7.17.1 40% 아세톤40% acetone 3030 5050 31.831.8 70, 80% 아세톤70, 80% Acetone 3030 5050 5252 10% 메탄올10% methanol 60 ∼ 8060 to 80 5050 15.115.1 40% 메탄올40% methanol 60 ∼ 8060 to 80 5050 25.225.2 70, 80% 메탄올70, 80% methanol 60 ∼ 8060 to 80 5050 56.256.2

대조군의 티로시나제 활성에 대한 저해도 (%)% Inhibition of tyrosinase activity in the control group 대 조 군Control 첨가 농도 (μg/mL)Concentration (μg / mL) 저해도 (%)Inhibition (%) 코지산Kojisan 5050 51.051.0 하이드로퀴논Hydroquinone 5050 5.05.0 아부틴Abutin 5050 7.07.0 4-하이드로아니솔4-hydroanisole 5050 3.03.0 아스코빅산Ascorbic acid 5050 20.020.0 레틴올Retinol 5050 4.94.9 하이드로코티손Hydrocortisone 5050 3.73.7

<실시예 3> 포도씨 추출물의 멜라닌 생합성 저해 활성 조사<Example 3> Melanin biosynthesis inhibitory activity of grape seed extract

상기 실시예 1에서 제조한 분말 상태의 포도씨 추출물의 멜라닌 생합성 저해 활성을 조사하기 위하여, 멜라닌 생합성 미생물인 스트렙토마이세스 비키니엔시스 B-1049 (Streptomyces bikiniensis NRRL B-1049)를 사용하였다. 구체적으로 상기 스트렙토마이세스 비키니엔시스 균주를 V-8 쥬스 (Cambell Soup Co., USA) 200mL, 포도당 (glucose) 2g, 효모 추출물 (yeast extract) 2g, CaCO31g, 박토 아가 2g과 증류수 800mL을 함유하는 pH 7.2의 파파비자스 VDYA (Papavizas' VDYA(15)) 사면 배지에 접종하고 이를 28℃에서 2주일간 배양한 다음 상기 사면 배양배지 표면에 2mL의 증류수를 가하여 기균사에 형성된 포자를 백금이로 긁어내고 포자 현탁액을 만든 다음, 이 포자 현탁액을 멸균된 시험관에 냉동 보관하였다.In order to investigate the melanin biosynthesis inhibitory activity of the powdered grape seed extract prepared in Example 1, melanin biosynthesis microorganism Streptomyces bikiniensis B-1049 (Streptomyces bikiniensis NRRL B-1049) was used. Specifically, the Streptomyces bikini strain contains V-8 juice (Cambell Soup Co., USA) 200mL, glucose (2g), yeast extract (2g), CaCO 3 1g, 2g Bakto agar and 800mL distilled water Inoculated into Papavizas' VDYA (15) slope medium at pH 7.2 and incubated at 28 ° C. for 2 weeks, then 2 mL of distilled water was added to the surface of the slope culture medium to form spores formed in Bacillus mycelia. The spore suspension was scraped off and the spore suspension was stored frozen in sterile test tubes.

또한, 포도당 1.5%, L-타이로신 0.05%, L-아스파라진 0.1%, K2HPO40.05%, MgSO4·7H2O 0.05%, NaCl 0.05%, FeSO4·7H2O 0.001%, 박토 아가 2% 를 함유하는 타이로신 아가 (ISP No. 7) 배지 조성에 박토 효모 추출물 (Bacto-yeast extract)을 0.2% 로 첨가하여 고체 배지를 만들고 멸균하여 피트리디쉬 (90mm i.d.)당 40 mL로 분주하였다. 이렇게 제작한 아가 플레이트에 각 플레이트당 0.4mL의 상기 S. bikiniensis 포자 현탁액을 가하여 유리 하키 바 (glass hockey bar)로 균일하게 도포하였다. 다음 배지 표면을 건조시키고 이에 50μL의 시료를 적신 8mm 직경의 종이 디스크 (paper disc, Toyo Roshi Kasha Ltd., Japan)를 올려놓아 28℃ 조건에서 48시간 동안 배양함으로 멜라닌 생성 저해환 (inhibition zone, mm)이 생성되도록 하였다. 이 멜라닌 생성 저해환의 크기는 배지의 배면에서 계측하였고, 이 때 대조군으로는 코지산, 하이드로퀴논, 아부틴, 4-하이드로아니솔을 사용하였다.In addition, glucose 1.5%, L-tyrosine 0.05%, L-asparagine 0.1%, K 2 HPO 4 0.05%, MgSO 4 · 7H 2 O 0.05%, NaCl 0.05%, FeSO 4 · 7H 2 O 0.001%, bacto agar Bacto-yeast extract was added to the tyrosine agar (ISP No. 7) medium composition containing 2% by 0.2% to make a solid medium, and sterilized and dispensed at 40 mL per phytidish (90 mm id). . 0.4 mL of the above S. bikiniensis spore suspension was added to each agar plate thus prepared, and uniformly coated with a glass hockey bar. Next, the surface of the medium was dried and placed on an 8 mm diameter paper disc (Toyo Roshi Kasha Ltd., Japan) soaked with 50 μL of the sample and incubated at 28 ° C. for 48 hours to inhibit the melanogenesis inhibition zone (mm). ) Is generated. The size of the melanogenesis inhibitory ring was measured on the back of the medium, and koji acid, hydroquinone, arbutin, and 4-hydroanisole were used as controls.

그 결과, 열수 추출물, 70∼80% 아세톤의 포도씨 추출물, 가열조건에서의 70∼80% 에탄올 또는 메탄올의 포도씨 추출물에서 저해환이 비교적 크고 깨끗하게 나타났다 (도 2 참조).As a result, the inhibitory ring was relatively large and clear in hot water extracts, 70-80% acetone grape seed extracts, and 70-80% ethanol or methanol grape seed extracts under heating conditions (see FIG. 2).

스트렙토마이세스 비키니엔시스 균주에서 포도씨 추출물의 멜라닌 생합성에 대한 저해도Inhibition of Melanin Biosynthesis of Grape Seed Extract in Streptomyces Bikinssis Strains 추출 용매Extraction solvent 추출 온도 (℃)Extraction temperature (℃) 첨가 농도 (%)Concentration (%) 저해환(mm)Inhibitory ring (mm) water 80 ∼ 9580 to 95 88 13.013.0 10% 에탄올10% ethanol 3030 88 9.09.0 40% 에탄올40% ethanol 3030 88 10.010.0 70, 80% 에탄올70, 80% Ethanol 3030 88 11.011.0 10% 에탄올10% ethanol 60 ∼ 8060 to 80 88 9.09.0 40% 에탄올40% ethanol 60 ∼ 8060 to 80 88 12.012.0 70, 80% 에탄올70, 80% Ethanol 60 ∼ 8060 to 80 88 14.514.5 99% 에탄올99% ethanol 60 ∼ 7560 to 75 88 12.012.0 10% 아세톤10% acetone 3030 88 8.58.5 40% 아세톤40% acetone 3030 88 12.512.5 70, 80% 아세톤70, 80% Acetone 3030 88 13.513.5 10% 메탄올10% methanol 60 ∼ 8060 to 80 88 9.59.5 40% 메탄올40% methanol 60 ∼ 8060 to 80 88 12.012.0 70, 80% 메탄올70, 80% methanol 60 ∼ 8060 to 80 88 13.013.0

대조군의 스트렙토마이세스 비키니엔시스의 멜라닌 생합성에 대한 저해도Inhibition of Melanin Biosynthesis of Streptomyces Bikinensis in the Control Group 대 조 군Control 첨가 농도 (%)Concentration (%) 저해환 (mm)Inhibitory ring (mm) 코지산Kojisan 88 1212 하이드로퀴논Hydroquinone 1.71.7 1515 아부틴Abutin 88 00 4-하이드로아니솔4-hydroanisole 88 1414

<제조예 1><Production example 1>

포도씨 추출물을 함유한 화장료 중 유연 화장수 처방예는 다음과 같다. 여기서 포도씨 추출물은 실시예 1에서 얻은 가열 조건의 75% 에탄올 추출물을 사용하였다.An example of the prescription of a flexible lotion among cosmetics containing grape seed extract is as follows. The grape seed extract used 75% ethanol extract of the heating conditions obtained in Example 1.

중량부Parts by weight

포도씨 추출물 0.01Grape Seed Extract 0.01

글리세린 3.0Glycerin 3.0

부틸렌글리콜 2.0Butylene Glycol 2.0

프로필렌글리콜 2.0Propylene Glycol 2.0

카르복시비닐폴리머 0.1Carboxy Vinyl Polymer 0.1

에탄올 10.0Ethanol 10.0

트리에탄올아민 0.1Triethanolamine 0.1

방부제 미량Preservative traces

색소 미량A small amount of pigment

향료 미량A small amount of spices

정제수 잔액Purified Water Balance

계 100.0Total 100.0

<제조예 2><Production example 2>

포도씨 추출물을 함유한 화장료 중 영양 화장수 처방예는 다음과 같다. 여기서 포도씨 추출물은 상기 제조예와 동일하다.An example of nutritional lotion prescription among cosmetics containing grape seed extract is as follows. The grape seed extract is the same as the preparation example.

중량부Parts by weight

포도씨 추출물 0.01Grape Seed Extract 0.01

밀납 4.0Beeswax 4.0

폴리솔베이트 60 1.5Polysorbate 60 1.5

솔비탄세스퀴올레이트 0.5Solbitan Sesquioleate 0.5

유동파라핀 5.0Liquid Paraffin 5.0

스쿠알란 5.0Squalane 5.0

카프릴릭/카프릭트리글리세라이드 5.0Caprylic / Capric Triglycerides 5.0

글리세린 3.0Glycerin 3.0

부틸렌글리콜 3.0Butylene Glycol 3.0

프로필렌글리콜 3.0Propylene Glycol 3.0

카르복시비닐폴리머 0.1Carboxy Vinyl Polymer 0.1

트리에탄올아민 0.2Triethanolamine 0.2

방부제 미량Preservative traces

색소 미량A small amount of pigment

향료 미량A small amount of spices

정제수 잔액Purified Water Balance

계 100.0Total 100.0

<제조예 3><Production example 3>

포도씨 추출물을 함유한 화장료 중 영양크림 처방예는 다음과 같다. 여기서 포도씨 추출물은 상기 제조예와 동일하다.An example of nutritional cream prescription among cosmetics containing grape seed extract is as follows. The grape seed extract is the same as the preparation example.

중량부Parts by weight

포도씨 추출물 0.005Grape Seed Extract 0.005

밀납 10.0Beeswax 10.0

폴리솔베이트 60 1.5Polysorbate 60 1.5

솔비탄세스퀴올레이트 0.5Solbitan Sesquioleate 0.5

유동파라핀 10.0Liquid Paraffin 10.0

스쿠알란 5.0Squalane 5.0

카프릴릭/카프릭트리글리세라이드 5.0Caprylic / Capric Triglycerides 5.0

글리세린 5.0Glycerin 5.0

부틸렌글리콜 3.0Butylene Glycol 3.0

프로필렌글리콜 3.0Propylene Glycol 3.0

트리에탄올아민 0.2Triethanolamine 0.2

방부제 미량Preservative traces

색소 미량A small amount of pigment

향료 미량A small amount of spices

정제수 잔액Purified Water Balance

계 100.0Total 100.0

<제조예 4><Production example 4>

포도씨 추출물을 함유한 화장료 중 맛사지크림 처방예는 다음과 같다. 여기서 포도씨 추출물은 상기 제조예와 동일하다.A massage cream prescription example of a cosmetic containing grape seed extract is as follows. The grape seed extract is the same as the preparation example.

중량부Parts by weight

포도씨 추출물 0.005Grape Seed Extract 0.005

밀납 10.0Beeswax 10.0

폴리솔베이트 60 0.8Polysorbate 60 0.8

솔비탄세스퀴올레이트 0.5Solbitan Sesquioleate 0.5

유동파라핀 40.0Liquid Paraffin 40.0

스쿠알란 5.0Squalane 5.0

카프릴릭/카프릭트리글리세라이드 4.0Caprylic / Capric Triglycerides 4.0

글리세린 5.0Glycerin 5.0

부틸렌글리콜 3.0Butylene Glycol 3.0

프로필렌글리콜 3.0Propylene Glycol 3.0

트리에탄올아민 0.2Triethanolamine 0.2

방부제 미량Preservative traces

색소 미량A small amount of pigment

향료 미량A small amount of spices

정제수 잔액Purified Water Balance

계 100.0Total 100.0

<제조예 5><Production example 5>

포도씨 추출물을 함유한 화장료 중 팩의 처방예는 다음과 같다. 여기서 포도씨 추출물은 상기 제조예와 동일하다.A prescription example of a pack of cosmetics containing grape seed extract is as follows. The grape seed extract is the same as the preparation example.

중량부Parts by weight

포도씨 추출물 0.005Grape Seed Extract 0.005

폴리비닐알콜 13.0Polyvinyl Alcohol 13.0

소듐카르복시메틸셀룰로스 0.2Sodium Carboxymethylcellulose 0.2

알란토인 0.1Allantoin 0.1

노닐페닐에테르 0.3Nonylphenyl Ether 0.3

방부제 미량Preservative traces

색소 미량A small amount of pigment

향료 미량A small amount of spices

정제수 잔액Purified Water Balance

계 100.0Total 100.0

<실험예 1> 피부의 색소 침착 억제<Experiment 1> Suppression of pigmentation of skin

건강한 남녀 20명의 실험 대상자의 양 팔 하박부에 2×2cm2의 부위를 설정하였다. 실험 대상 부위에만 자외선이 조사되도록 알루미늄 호일을 팔에 씌우고 10 cm 거리에서 일본 도시바 (주) 제 FL20S BLB 램프 및 FL20S E-30 램프를 각 2개 동시에 0.8×107erg/cm3/회로 1일 1회씩 연속 3회 조사하였다. 조사전에 실험 대상 부위를 70% 이소프로필알콜 수용액으로 잘 세척하였다. 조사후 자외선 조사 부위에 포도씨 추출물을 함유한 제조예 1 ∼ 5의 처방을 1일 3회씩 도포하였다. 3주 도포한 후에 육안으로 색소 침착도를 판정하고, 실험군이 대조군 (기제만 도포)에 비하여 색소 침착을 얼마나 억제하였는가를 현저한 효과, 유효, 무효의 3단계로 평가하였다. 표 6에서 나타난 바와 같이 유효 이상의 양성 효과가 높게 나타남으로써 탁월하게 색소 침착이 억제되는 효과를 보여주었다.A site of 2 × 2 cm 2 was set in the lower arm of both arms of 20 healthy men and women. Put the aluminum foil on the arm so that the ultraviolet ray is irradiated only on the test target area, and at the same time, each of the two FL20S BLB lamps and the FL20S E-30 lamps manufactured by Toshiba, Japan, at the same time, 10 cm at the same time, 0.8 × 10 7 erg / cm 3 / circuit 1 day One survey was conducted three times consecutively. The area to be tested was well washed with an aqueous 70% isopropyl alcohol solution before irradiation. After irradiation, the formulations of Preparation Examples 1 to 5 containing grape seed extract were applied three times a day. After 3 weeks of application, the degree of pigmentation was visually determined, and how much the experimental group suppressed the pigmentation compared to the control group (base only) was evaluated in three stages of remarkable effect, effectiveness, and invalidity. As shown in Table 6, the positive effect was shown to be higher than the effective one, showing the effect of inhibiting pigmentation excellently.

실험군Experimental group 현저한 효과 (명)Significant Effect (People) 유효 (명)Effective (persons) 무효 (명)Void (persons) 제조예 1Preparation Example 1 22 1111 77 제조예 2Preparation Example 2 22 1212 66 제조예 3Preparation Example 3 33 1313 44 제조예 4Preparation Example 4 22 1313 55 제조예 5Preparation Example 5 1One 1313 66

상기에서 살펴본 바와 같이, 본 발명의 포도씨 추출물은 천연물로부터 제조하여 부작용이 전혀 없고, 티로시나제 활성을 저해하여 탁월하게 멜라닌 생성을 억제하므로 피부 노화 방지, 피부 보호 및 미백 기능을 가지는 화장료, 기미, 주근깨, 반점 또는 임신기 과색소 침착 (hyperpigmentation) 등의 과잉 색소증 치료제 및 식품의 갈변을 억제하는 식품 첨가제 등으로 유용하다.As described above, the grape seed extract of the present invention is prepared from natural products, has no side effects, and inhibits tyrosinase activity, thereby inhibiting melanin production. It is useful as a therapeutic agent for hyperpigmentation such as spots or gestational hyperpigmentation, and as a food additive for suppressing browning of food.

Claims (6)

물 또는 유기용매를 사용하여 추출한 티로시나제 저해 활성을 가지는 포도씨 추출물.Grape seed extract having tyrosinase inhibitory activity extracted using water or an organic solvent. 제 1항에 있어서, 유기용매로는 에탄올, 메탄올 또는 아세톤을 사용하고, 60 ∼ 90% 농도 범위의 유기용매로 열수 조건 또는 가열 조건에서 포도씨 분말을 추출하여 제조하는 것을 특징으로 하는 포도씨 추출물.[Claim 2] The grape seed extract according to claim 1, wherein ethanol, methanol or acetone is used as the organic solvent, and grape seed powder is prepared by extracting grape seed powder under hydrothermal or heating conditions with an organic solvent in a concentration range of 60 to 90%. 제 1항의 포도씨 추출물을 유효성분으로 하는 멜라닌 생성 억제, 피부 노화 방지, 피부 보호 및 미백 기능을 가지는 화장료.Claim 1, a cosmetic having melanin production, skin aging, skin protection and whitening function as an active ingredient grape seed extract. 제 1항의 포도씨 추출물을 유효성분으로 하는 멜라닌 생성 억제제용 약학적 조성물.Pharmaceutical composition for the production of melanin using the grape seed extract of claim 1 as an active ingredient. 제 4항에 있어서, 기미, 주근깨, 반점 또는 임신기 과색소 침착 (hyperpigmentation)을 포함하는 과잉 색소증의 치료에 사용되는 약학적 조성물.The pharmaceutical composition according to claim 4, which is used for the treatment of hyperpigmentation including blemishes, freckles, spots or gestational hyperpigmentation. 제 1항의 포도씨 추출물을 유효 성분으로 하여 과일, 야채 및 생선을 포함하는 식품의 갈변을 억제하는 식품 첨가물.A food additive for inhibiting browning of foods including fruits, vegetables and fish using the grape seed extract of claim 1 as an active ingredient.
KR1019980051189A 1998-11-27 1998-11-27 Grape seed extract as tyrosinase inhibitor KR20000034037A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1019980051189A KR20000034037A (en) 1998-11-27 1998-11-27 Grape seed extract as tyrosinase inhibitor
CN99103166A CN1255357A (en) 1998-11-27 1999-03-24 Grape seed extract with strong anti-tyrosine enzyme activity and its application
JP11124735A JP2000159681A (en) 1998-11-27 1999-04-30 Extract from grape seed and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980051189A KR20000034037A (en) 1998-11-27 1998-11-27 Grape seed extract as tyrosinase inhibitor

Publications (1)

Publication Number Publication Date
KR20000034037A true KR20000034037A (en) 2000-06-15

Family

ID=19559987

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980051189A KR20000034037A (en) 1998-11-27 1998-11-27 Grape seed extract as tyrosinase inhibitor

Country Status (3)

Country Link
JP (1) JP2000159681A (en)
KR (1) KR20000034037A (en)
CN (1) CN1255357A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030023172A (en) * 2001-09-12 2003-03-19 주식회사 퓨쳐바이오테크 fruit bioactive component and extrating process thereof
KR100409041B1 (en) * 2001-03-09 2003-12-18 학교법인 청강학원 Rice coated with fat-removed grape seed extracts
KR100830403B1 (en) * 2006-09-28 2008-05-20 라호열 Natural cosmetic composition having the cactus fermented liquid and grape seed extracts
KR100854116B1 (en) * 2007-03-20 2008-08-26 주식회사 케이티앤지 Composition for skin whitening comprising extracts of torilis japonica
US20130266638A1 (en) * 2008-05-30 2013-10-10 Dynamis Pharmaceuticals, Inc. Natural product inhibitors of 3dg
WO2015148617A1 (en) * 2014-03-25 2015-10-01 Active Concepts, LLC H3 antagonist by-product, its manufacture and method of using by-product to reduce pigmentation in skin
KR20170122811A (en) * 2015-04-09 2017-11-06 아이에스피 인베스트먼츠 엘엘씨 A cosmetic treatment method for protecting skin from contamination and improving skin regeneration

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808190B1 (en) * 2000-04-28 2002-06-21 Oreal PLANT EXTRACT OF THE SPECIES VITIS VINIFERA AS NO-SYNTHASE INHIBITOR AND USES
CN1111068C (en) * 2000-07-27 2003-06-11 上海北医大生物科技有限公司 Strong anti-oxidative composite capsule of grape seed extract OPC and its producing method
ES2172475B1 (en) * 2001-03-02 2003-12-16 Raoul J Hermitte COSMETIC COMPOSITIONS OBTAINED FROM PLANTS OF GENDER VITIS AND ALFAHYDROXIACIDES.
US7955628B2 (en) 2004-12-14 2011-06-07 Access Business Group International Llc Methods of using nonpolar grape seed extracts to stimulate tyrosinase expression or melanin synthesis
US7875302B2 (en) 2004-12-14 2011-01-25 Access Business Group International Llc Methods of using grape seed extract to stimulate tyrosinase gene expression
RU2012155854A (en) * 2010-06-30 2014-06-27 Нестек С.А. APPLICATION OF ACID ACID AND ITS DERIVATIVES IN A BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR REGULATING SKIN PIGMENTATION
JP6074286B2 (en) * 2013-02-21 2017-02-01 株式会社ダイセル Functional composition
CN107007792A (en) * 2017-04-27 2017-08-04 福建省康馨生物科技有限公司 A kind of pharmaceutical composition of nti-freckle and preparation method thereof, preparation and application
JP7239310B2 (en) * 2018-12-12 2023-03-14 花王株式会社 1-phenyl-2-phenylethane derivative
WO2022171292A1 (en) 2021-02-12 2022-08-18 Symrise Ag Medicament for prevention and treatment of hyperpigmentation
CN113234049B (en) * 2021-04-16 2023-12-22 广州纳丽生物科技有限公司 Tyrosinase inhibitor based on grape seed extraction and extraction method and application thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100409041B1 (en) * 2001-03-09 2003-12-18 학교법인 청강학원 Rice coated with fat-removed grape seed extracts
KR20030023172A (en) * 2001-09-12 2003-03-19 주식회사 퓨쳐바이오테크 fruit bioactive component and extrating process thereof
KR100830403B1 (en) * 2006-09-28 2008-05-20 라호열 Natural cosmetic composition having the cactus fermented liquid and grape seed extracts
KR100854116B1 (en) * 2007-03-20 2008-08-26 주식회사 케이티앤지 Composition for skin whitening comprising extracts of torilis japonica
US20130266638A1 (en) * 2008-05-30 2013-10-10 Dynamis Pharmaceuticals, Inc. Natural product inhibitors of 3dg
WO2015148617A1 (en) * 2014-03-25 2015-10-01 Active Concepts, LLC H3 antagonist by-product, its manufacture and method of using by-product to reduce pigmentation in skin
KR20170122811A (en) * 2015-04-09 2017-11-06 아이에스피 인베스트먼츠 엘엘씨 A cosmetic treatment method for protecting skin from contamination and improving skin regeneration

Also Published As

Publication number Publication date
JP2000159681A (en) 2000-06-13
CN1255357A (en) 2000-06-07

Similar Documents

Publication Publication Date Title
KR20000034037A (en) Grape seed extract as tyrosinase inhibitor
KR101997893B1 (en) Method of increase the bioactive effectiveness of sprout ginseng
KR101492003B1 (en) Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products
KR20210114893A (en) Cosmetic and OTC drug composition comprising peach fermented extract as an active ingredient
KR20010017516A (en) New Melanin Biosynthesis Inhibitors
KR20190117082A (en) Composition for anti-oxidation, anti-inflammation, anti-diabetes, whitening, anti-wrinkle, or anti-gout comprising extract of Rubies apple peel
JP2005253463A (en) Fermented product of acerola
KR20200052867A (en) Composition for anti-inflammation, anti-diabetes, whitening, or inhibition of gout comprising extract of Ruby-S apple peel as an active ingredient
KR102442861B1 (en) Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing Pediococcus acidilactici PMC48 strain a culture medium thereof as an active ingredient
EP2123290A1 (en) Melanogenesis inhibitory composition
KR100802005B1 (en) Melanin Biosynthesis Inhibitors which using of ginsenosides
KR102304146B1 (en) Composition for skin whitening and composition for ultraviolet-proof comprising the extract of fermented Astragalus membranaceus Bunge
KR102370528B1 (en) Compositions containing Beta vulgaris fermentation extract
KR20160091037A (en) Composition comprising gooseberry or glutathione
KR102449136B1 (en) Compositions containing Taraxacum coreanum extract
KR20010084402A (en) Safflower Seeds Extracts Inhibiting Melanin Biosynthesis and Composition Comprising Same
KR102379698B1 (en) A composition for skin whitening or regeneration comprising Melandrium firmum extract
KR102139156B1 (en) Composition Comprising Enzyme Treated Extract of Red Ginseng and Gastrodia for Preventing or Improving Skin Wrinkle as Active Ingredient
KR20000047004A (en) Novel tyrosinase-inhibiting agent
KR20180024481A (en) Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract
KR20220018310A (en) Compositions containing black garlic extract
KR20000007943A (en) Whitening cosmetic containing extracts from a bamboo endothelium
KR102612332B1 (en) Compositions for skin whitening and anti-wrinkle containing fermented moringa extract
KR101778538B1 (en) Cosmetic composition comprising ginseng fruit Fermentation Product by Botrytis sp.
KR102401490B1 (en) Compositions containing Angelica gigas extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application